Novel Anti-TNF Shines in Rheumatoid Arthritis Trial - Medpage Today
6/24/2022 12:00:00 AM2 years 10 months ago
by John Gever
by John Gever
Trivalent 'nanobody' biologic engineered to accumulate in inflamed tissue
A new way of inhibiting tumor necrosis factor (TNF) for treating rheumatoid arthritis showed strong results in a phase II/III clinical trial, researchers said. About 75% to 80% of patients receiving… [+4908 chars]
full article...